
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co is positioning itself for continued growth and success in the growing behavioral health marketplace, with a strong demand for its services and impressive organic growth through expansions and M&A. The company's recent earnings beat and raised guidance, along with its efforts to clean up its story and improve its cash flow profile, make it a positive investment opportunity. Our price target for the company is $31, reflecting its higher EBITDA estimates and its focus on improving fundamentals and unlocking earnings potential from ramping facilities.
Bears say
Acadia Healthcare Co is a behavioral healthcare company with a diverse portfolio of facilities and services that includes acute inpatient psychiatric facilities, specialty treatment facilities, and residential treatment centers. While the company has shown positive financial momentum with increased guidance and improved operating efficiency, there are still underlying concerns about the operating environment, including increased bad debt and denials. Additionally, there are uncertainties surrounding the impact of the pandemic on demand for behavioral health services in the future. As such, the financial analyst has a negative outlook on the stock, with a neutral rating and a price target of $30.00, reflecting the recent stock appreciation.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares